Today we sent invoices to companies like Gilead Sciences, Johnson & Johnson, and Purdue Pharmaceuticals for our work to make COVID-19 testing, treatment, and vaccines available to all.
Our invoice describes our project and includes a small (very modest, really) first installment payment for our work to “to ensure publicly-funded diagnostic tools, treatment, and the COVID-19 vaccine will be sustainably priced, available to all and free at the point of delivery.”
To make sure there was no real confusion, we were let them know they were making a donation:
“We appreciate your timely payment. It’s a pleasure to work with you on this project. As always, your donation is tax-deductible.”
We know: invoicing pharma is not a sustainable fundraising model.
That’s why we so appreciate those of you who can chip in. Because of these donations that aren’t tied to contracts or specific programs we can make rapid, necessary changes to take on this crisis that other organizations can’t.
We created a global program with hundreds of participants in 10 days.
We couldn’t have done that with out you. You can help make sure testing, treatment, and the vaccine for COVID-19 is available to everyone: